These novel medications , Retatrutide, represent a significant advancement in addressing metabolic dysfunction and potentially related disorders. These drugs are classified as GLP-1 pathway agonists , https://safiyayqms369811.blogtov.com/22231266/tirzepatide-a-comprehensive-dive-into-incretin-compounds